Article
Stockholders to vote: Investments breathe life into ISTA Pharmaceuticals
Irvine, CA-ISTA Pharmaceuticals Inc. has secured $44 million in financing, including a $4 million bridge loan, to complete development work on late-stage ophthalmic products in the company's clinical pipeline.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Content
